Physician

Fariborz Gorouhi, M.D.

According to 2025 Medicare claims, Fariborz Gorouhi, M.D. (NPI: 1407058530) practices internal medicine in the Victoria, TX market, with the plurality of this provider's patient population coming from Victoria, TX. This provider's primary affiliated billing organization is CITIZEN'S MEDICAL CENTER COUNTY OF VICTORIA (NPI: 1205242088; TIN: 471158090) and primary practice location at 77901-5754. Gorouhi is affiliated with the The Rural Advantage LLC (ACO ID: A5257), Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), Main Street Rural Health Cottonwood ACO LLC (ACO ID: A5439), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gorouhi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 404 traditional Medicare patients, billed 20,583 HCPCS/CPT codes, and received $418,947 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,130 prescription claims across 357 beneficiaries totaling $4,814,125 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). 2023 DME data shows 11 claims. Open Payments data shows 2 records totaling $74. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $90,755 and ending at $418,947. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $774,544 to $4,814,125. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,636 to $1,927.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	189	3,632	$90,755
2016	377	24,524	$245,840
2017	526	80,097	$404,920
2018	565	66,399	$523,121
2019	570	21,531	$519,535
2020	519	18,023	$412,905
2021	618	14,907	$376,199
2022	433	13,406	$261,214
2023	418	20,747	$377,855
2024	404	20,583	$418,947

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	1,076	$774,544
2016	166	1,651	$1,392,383
2017	229	1,852	$1,702,919
2018	280	2,284	$1,970,834
2019	299	2,308	$2,684,161
2020	288	2,425	$2,743,153
2021	398	2,984	$3,424,136
2022	386	2,651	$4,494,288
2023	351	2,829	$4,351,299
2024	357	3,130	$4,814,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	120	$13,207
2016	11	113	$8,186
2017	N/R	147	$30,205
2018	N/R	25	$415
2019	N/R	24	$4,497
2020	N/R	13	$239
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$367
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	37	37	$173
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	52	82	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	313	1,392	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	41	46	$69
36415	Insertion of needle into vein for collection of blood sample	240	970	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Abiraterone Acetate	Abiraterone Acetate	101	3,030	$556,864
Jakafi	Ruxolitinib Phosphate	25	750	$441,316
Cabometyx	Cabozantinib S-Malate	16	480	$415,422
Revlimid	Lenalidomide	22	616	$363,366
Venclexta	Venetoclax	25	749	$336,810

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$74	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fariborz Gorouhi, M.D.?

Tedicare shows public-source Medicare data for Fariborz Gorouhi, M.D. (NPI 1407058530), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fariborz Gorouhi, M.D. have ACO affiliation data?

Fariborz Gorouhi, M.D. is shown with ACO affiliation data for The Rural Advantage LLC (MSSP, ACO ID A5257), Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334), Main Street Rural Health Cottonwood ACO LLC (MSSP, ACO ID A5439), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Fariborz Gorouhi, M.D.?

Fariborz Gorouhi, M.D. is linked to CITIZEN'S MEDICAL CENTER COUNTY OF VICTORIA (billing NPI 1205242088) in the available physician profile data.

Does Fariborz Gorouhi, M.D. have Open Payments data?

Fariborz Gorouhi, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.